| Hemophilia Treatment and Research | Lifetime | 7 | IT 3 | 99.68 |
| COVID-19 Clinical Research Studies | Lifetime | 82 | IT 7 | 99.44 |
| Hemostasis and retained surgical items | Lifetime | 4 | IT 2 | 99.52 |
| Platelet Disorders and Treatments | Lifetime | 31 | IT 5 | 99.49 |
| Blood groups and transfusion | Lifetime | 40 | IT 5 | 99.33 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 53 | IT 7 | 99.31 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 59 | IT 6 | 99.18 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 194 | IT 18 | 99.40 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 228 | IT 6 | 99.07 |
| Hemoglobinopathies and Related Disorders | Lifetime | 150 | IT 17 | 98.72 |
| COVID-19 Impact on Reproduction | Lifetime | 49 | IT 5 | 98.31 |
| Blood transfusion and management | Lifetime | 60 | IT 4 | 98.55 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 47 | IT 5 | 98.61 |
| Long-Term Effects of COVID-19 | Lifetime | 277 | IT 45 | 97.65 |
| Iron Metabolism and Disorders | Lifetime | 354 | IT 19 | 97.71 |
| Erythrocyte Function and Pathophysiology | Lifetime | 441 | IT 21 | 97.41 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 172 | IT 6 | 97.90 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 487 | IT 51 | 97.82 |
| Complement system in diseases | Lifetime | 298 | IT 11 | 97.16 |
| Blood donation and transfusion practices | Lifetime | 123 | IT 2 | 96.85 |
| Blood properties and coagulation | Lifetime | 382 | IT 15 | 96.49 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 638 | IT 64 | 97.27 |
| Cancer-related gene regulation | Lifetime | 900 | IT 14 | 96.05 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 524 | IT 68 | 96.38 |
| Erythropoietin and Anemia Treatment | Lifetime | 302 | IT 21 | 95.45 |
| COVID-19 impact on air quality | Lifetime | 113 | IT 7 | 90.70 |
| Blood disorders and treatments | Lifetime | 760 | IT 46 | 92.83 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 881 | IT 62 | 89.01 |
| Clinical Laboratory Practices and Quality Control | Lifetime | 447 | IT 36 | 88.34 |
| Intramuscular injections and effects | Lifetime | 230 | IT 5 | 84.08 |
| Doping in Sports | Lifetime | 734 | IT 18 | 63.78 |
| COVID-19 Clinical Research Studies | 2021-2025 | 221 | IT 19 | 98.85 |
| COVID-19 Impact on Reproduction | 2021-2025 | 33 | IT 2 | 97.82 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 323 | IT 16 | 98.61 |
| Long-Term Effects of COVID-19 | 2021-2025 | 385 | IT 66 | 96.31 |
| Platelet Disorders and Treatments | 2021-2025 | 74 | IT 9 | 96.91 |
| Hemophilia Treatment and Research | 2021-2025 | 40 | IT 5 | 97.33 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 175 | IT 16 | 89.34 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 162 | IT 13 | 84.73 |
| Blood groups and transfusion | 2021-2025 | 604 | IT 50 | 80.01 |
| Blood transfusion and management | 2021-2025 | 530 | IT 13 | 70.42 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 909 | IT 24 | 67.64 |
| Hemostasis and retained surgical items | 2021-2025 | 294 | IT 5 | 60.91 |
